Aclipse Therapeutics Alternatives & Competitors

12 companies similar to Aclipse Therapeutics — Aclipse develops novel and highly differentiated therapeutics to treat diseases...

Myogen

Advancing cardiovascular health with innovative small molecule therapeutics for unmet medi...

Series D $187.77M

Biopharma Biotechnology +3

MediciNova

Focused on innovative small-molecule therapeutics, addressing unmet medical needs with str...

Post-IPO Equity $136.00M

Biotechnology Health and Wellness +1

VITA PHARMA LIMITED

Pioneering advanced treatments to address significant unmet medical needs in chronic kidne...

2 Venture round $94.00M

Biotechnology Health Care +1

Yuanyin Bio

Pioneering the future of medicine with groundbreaking RNA technology to tackle unmet clini...

Series A $142.00M

Biopharma Biotechnology +1

Track all Aclipse Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Atlantic Healthcare

Innovating therapeutic solutions for gastrointestinal diseases and unmet patient needs wor...

Series B $62.00M

Biotechnology Health Care +1

Khloris Biosciences

Pioneering medical treatment using advanced stem cell technology to address critical cardi...

Venture round $5.00M

Biotechnology Life Sciences +1

IXALTIS SA

DEVELOPING INNOVATIVE TREATMENTS FOR GENITOURINARY TRACT DISORDERS

2 Venture round $8.00M

Toulouse, France

Biopharma Biotechnology +4

Nirogy Therapeutics

Pioneering innovative small molecules to disrupt metabolic and immune pathways, advancing...

2-10 Series A $18.50M

Biopharma Biotechnology +1

Microbion Corporation

Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic,...

16 Venture round

Bozeman, United States

Biotechnology Health Care +2

CytoAgents, Inc

Calming the Cytokine Storm, Rebalancing the Immune System. Accessible treatment for mult...

10 Series A $22.60M

Pittsburgh, United States

Biotechnology Health Care +1

Gemin X Pharmaceuticals

Advancing cancer care with innovative solutions to improve patient outcomes

Series E $71.26M

Biotechnology Health and Wellness +1

Calithera Biosciences

Targeting cancer, differently.

27 Post-IPO Equity

South San Francisco, Unit...

Biotechnology Health and Wellness +1

About Aclipse Therapeutics

Aclipse Therapeutics is a biotechnology and pharmaceutical startup founded in 2017 with a focus on developing novel and highly differentiated drugs to address diseases with high unmet medical needs. Their strategy involves reducing clinical development risk by combining a new and druggable understanding of disease path...

Taxonomy

Biopharmaceuticals, Therapeutics, Drug Development, Clinical Research, Disease Pathways, Unmet Medical Needs, Patent Barriers, Drug Molecules, Novel Drugs, Clinical Data, Druggable Targets

Frequently Asked Questions

Companies similar to Aclipse Therapeutics include Myogen, MediciNova, VITA PHARMA LIMITED, Yuanyin Bio, Atlantic Healthcare. They work in Biotechnology and Pharmaceutical and share Aclipse Therapeutics's focus on drug development, unmet medical needs and biopharmaceuticals.

Bounce Watch lists 12 companies that share Aclipse Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Aclipse Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Aclipse Therapeutics Profile Myogen Alternatives VITA PHARMA LIMITED Alternatives Yuanyin Bio Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Aclipse Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.